Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Neubig

Showing results (241-250 of 257) with videos related to

Pageof 26
Sort By:
Pharmacological Reviews|May 21, 2013
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsAnthony P Davenport, Stephen P H Alexander, Joanna L Sharman, et al.
Molecular Cancer Therapeutics|November 13, 2016
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing MelanomaAndrew J Haak, Kathryn M Appleton, Erika M Lisabeth, et al.
Journal of Medicinal Chemistry|April 6, 2019
5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for SclerodermaDylan J Kahl, Kim M Hutchings, Erika Mathes Lisabeth, et al.
Cancer Cell|July 2, 2019
RAC1<sup>P29S</sup> Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy ResistanceDaniël A Lionarons, David C Hancock, Sareena Rana, et al.
The American Journal of Pathology|February 15, 2015
Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosisThomas H Sisson, Iyabode O Ajayi, Natalya Subbotina, et al.
Pharmacological Reviews|July 17, 2014
International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligandsArthur Christopoulos, Jean-Pierre Changeux, William A Catterall, et al.
Nature|October 5, 2007
Phagocyte-derived catecholamines enhance acute inflammatory injuryMichael A Flierl, Daniel Rittirsch, Brian A Nadeau, et al.
Bioinformatics (Oxford, England)|May 27, 2010
GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge BaseGeorge Khelashvili, Kevin Dorff, Jufang Shan, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic sclerodermaKim M Hutchings, Erika M Lisabeth, Walajapet Rajeswaran, et al.
Cell|March 18, 2026
Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypesJing Xing, Mingdian Tan, Dmitry Leshchiner, et al.
Pageof 26

Showing results (241-250 of 257) with videos related to

Sort By:
Pageof 26
Pharmacological Reviews|May 21, 2013
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsAnthony P Davenport, Stephen P H Alexander, Joanna L Sharman, et al.
Molecular Cancer Therapeutics|November 13, 2016
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing MelanomaAndrew J Haak, Kathryn M Appleton, Erika M Lisabeth, et al.
Journal of Medicinal Chemistry|April 6, 2019
5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for SclerodermaDylan J Kahl, Kim M Hutchings, Erika Mathes Lisabeth, et al.
Cancer Cell|July 2, 2019
RAC1<sup>P29S</sup> Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy ResistanceDaniël A Lionarons, David C Hancock, Sareena Rana, et al.
The American Journal of Pathology|February 15, 2015
Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosisThomas H Sisson, Iyabode O Ajayi, Natalya Subbotina, et al.
Pharmacological Reviews|July 17, 2014
International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligandsArthur Christopoulos, Jean-Pierre Changeux, William A Catterall, et al.
Nature|October 5, 2007
Phagocyte-derived catecholamines enhance acute inflammatory injuryMichael A Flierl, Daniel Rittirsch, Brian A Nadeau, et al.
Bioinformatics (Oxford, England)|May 27, 2010
GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge BaseGeorge Khelashvili, Kevin Dorff, Jufang Shan, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic sclerodermaKim M Hutchings, Erika M Lisabeth, Walajapet Rajeswaran, et al.
Cell|March 18, 2026
Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypesJing Xing, Mingdian Tan, Dmitry Leshchiner, et al.
Pageof 26